Loading...
Loading...
NDRA| Name | Value |
|---|---|
| Revenues | 428.4K |
| Cost of Revenue | 61.2K |
| Gross Profit | 367.2K |
| Operating Expense | 1,396.5K |
| Operating I/L | -1,457.8K |
| Other Income/Expense | -1.8K |
| Interest Income | 0.0K |
| Pretax | -1,459.5K |
| Income Tax Expense | 0.0K |
| Net Income/Loss | -1,459.5K |
ENDRA Life Sciences Inc. develops thermo-acoustic enhanced ultrasound technology for clinical diagnostic imaging and treatment. Their technology improves the capabilities of ultrasound by transmitting sound waves to visualize tissues, organs, and blood in the body. This technology is used in the treatment of nonalcoholic fatty liver disease, temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. The company also offers diagnostic imaging technologies such as computed tomography, magnetic resonance imaging, and ultrasound for guiding treatment and gathering medical information about various conditions.
